Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Yogindra, Persaud"'
Autor:
James A. Fagin, Ronald Ghossein, Filippo Giancotti, Kety H. Huberman, Adriana Heguy, Agnes Viale, Suresh C. Jhanwar, Yuqiang Fang, Gisele Oler, Yogindra Persaud, Barry S. Taylor, Ian Ganly, Vicki E. Smith, Francesca Voza, Jeffrey A. Knauf, Iňigo Landa, Brian R. Untch, Julio C. Ricarte-Filho, Maria E.R. Garcia-Rendueles
Supplementary Figure S1. Loss of heterozygosity of Ch22q genes in poorly differentiated (PDTC) and anaplastic thyroid cancers (ATC). Supplementary Figure S2. Focal NF2-exon 4 homozygous deletion in KHM-5M anaplastic thyroid cancer cells. Supplementar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00432f909159d62c37d773b52e5a894b
https://doi.org/10.1158/2159-8290.22530699
https://doi.org/10.1158/2159-8290.22530699
Autor:
David B. Solit, Philip B. Paty, Adriana Heguy, Leonard B. Saltz, Marc Ladanyi, Alex Lash, John M. Mariadason, Suresh C. Jhanwar, James A. Fagin, Douglas A. Levine, Yogindra Persaud, Julio Cezar Ricarte Filho, Kety Huberman, Manda Wilson, Ensar Halilovic, Dhananjay Chitale, Barry S. Taylor, Christine A. Pratilas, Zhaoshi Zeng, Efsevia Vakiani, Manickam Janakiraman
Supplementary Figures 1-3, Tables 1-9, Methods from Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b62ed49f3f3781aad5e9033366ee6c4f
https://doi.org/10.1158/0008-5472.22383576.v1
https://doi.org/10.1158/0008-5472.22383576.v1
Autor:
David B. Solit, Neal Rosen, Adi Gazdar, Marc Ladanyi, Shinichi Toyooka, William Pao, Barry S. Taylor, Manickam Janakiraman, Ayana Sawai, Hiromasa Yamamoto, Hisayuki Shigematsu, Dhananjay Chitale, Junichi Soh, Yogindra Persaud, Ensar Halilovic, Aphrothiti J. Hanrahan, Christine A. Pratilas
Supplementary Materials from Genetic Predictors of MEK Dependence in Non–Small Cell Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d48bead40b73c2410daffc0d6f0af94
https://doi.org/10.1158/0008-5472.22375757
https://doi.org/10.1158/0008-5472.22375757
Autor:
David B. Solit, Philip B. Paty, Adriana Heguy, Leonard B. Saltz, Marc Ladanyi, Alex Lash, John M. Mariadason, Suresh C. Jhanwar, James A. Fagin, Douglas A. Levine, Yogindra Persaud, Julio Cezar Ricarte Filho, Kety Huberman, Manda Wilson, Ensar Halilovic, Dhananjay Chitale, Barry S. Taylor, Christine A. Pratilas, Zhaoshi Zeng, Efsevia Vakiani, Manickam Janakiraman
Mutations in RAS proteins occur widely in human cancer. Prompted by the confirmation of KRAS mutation as a predictive biomarker of response to epidermal growth factor receptor (EGFR)–targeted therapies, limited clinical testing for RAS pathway muta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4155bfa59f0aaa6b4ba6253d78cf53a
https://doi.org/10.1158/0008-5472.c.6500589
https://doi.org/10.1158/0008-5472.c.6500589
Autor:
Yogindra Persaud, Belinda N. Mandrell, Akshay Sharma, Yvonne Carroll, Mary Irvine, Yunusa Olufadi, Guolian Kang, Diego R. Hijano, Parul Rai, Jane S. Hankins, Liza‐Marie Johnson
Publikováno v:
Pediatric Blood & Cancer. 70
Autor:
Eman T, Al-Antary, Rewa, Arar, Yogindra, Persaud, Basil M, Fathalla, Madhvi, Rajpurkar, Kanta, Bhambhani
Publikováno v:
Journal of Pediatric Hematology/Oncology. 44:e812-e815
The understanding of coronavirus disease 2019 (COVID-19) immune dysregulation is evolving. Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with alternations in both innate and adaptive immunity, probably caused by a complex int
Autor:
Yogindra Persaud, Marjilla Seddiq, Yi-Mi Wu, Dan Robinson, Poulik Janet, Sandeep Sood, Deniz Altinok, JOHN ROARTY, James Geller, Rajen Mody, Jeffrey Taub
Retinoblastoma is the most common ocular tumor of childhood with cure rates exceeding 95%. Patients with high-risk features typically relapse within 3 years of diagnosis. We report a patient with low-risk bilateral retinoblastoma who suffered systemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62bfd3aaa6f54bed43aa10fca24f462f
https://doi.org/10.22541/au.164864911.18158063/v1
https://doi.org/10.22541/au.164864911.18158063/v1
Autor:
Yi-Mi Wu, John D. Roarty, Rajen Mody, Yogindra Persaud, Marjilla Seddiq, Jeffrey W. Taub, Janet Poulik, Deniz Altinok, Dan R. Robinson
Publikováno v:
Pediatric Blood & Cancer. 68
Autor:
Yogindra Persaud, Shruti Bagla, Yaddanapudi Ravindranath, Christina Shanti, Hamza S Gorsi, Bahig M. Shehata
Publikováno v:
Pediatric Blood & Cancer. 68
Non Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) are rare in the pediatric age group, accounting for 1-7% of all pediatric tumors. Leiomyosarcoma, a subtype of NRSTS, is exceedingly rare in pediatric population. Due to the rarity of this condition,
Autor:
Michael U. Callaghan, Jennifer Lafferty, Yogindra Persaud, Süreyya Savaşan, Serina B. Beydoun
Publikováno v:
Pediatric Blood & Cancer. 67
Treatment of refractory Evans syndrome (ES) remains a challenge in hematology practice. Due to rarity of this condition, evidence-based approaches are limited and often treatment choices stem from small case series or anecdotal experiences. There is